271
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Management of ventricular arrhythmias in structural heart disease

, &
Pages 549-559 | Received 16 Feb 2015, Accepted 24 Apr 2015, Published online: 13 May 2015

References

  • Jackson E , Bellenger N , Seddon M , Harden S , Peebles C . Ischaemic and non-ischaemic cardiomyopathies–cardiac MRI appearances with delayed enhancement. Clin Radiol 2007;62:395–403.
  • de Bakker JM , van Capelle FJ , Janse MJ , Wilde AA , Coronel R , Becker AE , et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 1988;77:589–606.
  • Kienzle MG , Miller J , Falcone RA , Harken A , Josephson ME . Intraoperative endocardial mapping during sinus rhythm: relationship to site of origin of ventricular tachycardia. Circulation 1984;70:957–65.
  • Cassidy DM , Vassallo JA , Buxton AE , Doherty JU , Marchlinski FE , Josephson ME . The value of catheter mapping during sinus rhythm to localize site of origin of ventricular tachycardia. Circulation 1984;69:1103–10.
  • de Bakker JM , Coronel R , Tasseron S , Wilde AA , Opthof T , Janse MJ , et al. Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: role of the arrangement of surviving cardiac fibers. J Am Coll Cardiol 1990;15:1594–607.
  • Peters NS , Green CR , Poole-Wilson PA , Severs NJ . Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 1993;88:864–75.
  • Spear JF , Michelson EL , Moore EN . Cellular electrophysiologic characteristics of chronically infarcted myocardium in dogs susceptible to sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1983;1:1099–110.
  • Gardner PI , Ursell PC , Fenoglio JJ Jr , Wit AL . Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 1985;72:596–611.
  • Ursell PC , Gardner PI , Albala A , Fenoglio JJ Jr , Wit AL . Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing. Circ Res 1985;56:436–51.
  • Rosman J , Hanon S , Shapiro M , Evans SJ , Schweitzer P . Triggers of Sustained Monomorphic Ventricular Tachycardia Differ Among Patients with Varying Etiologies of Left Ventricular Dysfunction. Ann Noninvasive Electrocardiol 2006;11:113–17.
  • Huelsing DJ , Spitzer KW , Pollard AE . Spontaneous activity induced in rabbit Purkinje myocytes during coupling to a depolarized model cell. Cardiovasc Res 2003;59:620–7.
  • Spitzer KW , Pollard AE , Yang L , Zaniboni M , Cordeiro JM , Huelsing DJ . Cell-to-cell electrical interactions during early and late repolarization. J Cardiovasc Electrophysiol 2006;17:S8–S14.
  • Bogun F , Crawford T , Chalfoun N , Kuhne M , Sarrazin JF , Wells D , et al. Relationship of frequent postinfarction premature ventricular complexes to the reentry circuit of scar-related ventricular tachycardia. Heart Rhythm 2008;5:367–74.
  • Soejima K , Stevenson W , Sapp J , Selwyn A , Couper G , Epstein LM . Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol 2004;43:1834–42.
  • Delacretaz E , Stevenson W , Ellison K , Maisel W , Friedman P . Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol 2000;11:11–17.
  • Soejima K , Suzuki M , Maisel WH , Brunckhorst CB , Delacretaz E , Blier L , et al. Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping. Circulation 2001;104:664–9.
  • Philips B , Madhavan S , James C , Tichnell C , Murray B , Needleman M , et al. High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol 2013;6:160–6.
  • Lopera G , Stevenson WG , Soejima K , Maisel WH , Koplan B , Sapp JL , et al. Identification and ablation of three types of ventricular tachycardia involving the his-purkinje system in patients with heart disease. J Cardiovasc Electrophysiol 2004;15:52–8.
  • Chow AW , Segal OR , Davies DW , Peters NS . Mechanism of pacing-induced ventricular fibrillation in the infarcted human heart. Circulation 2004;110:1725–30.
  • Josephson ME , Spielman SR , Greenspan AM , Horowitz LN . Mechanism of ventricular fibrillation in man. Observations based on electrode catheter recordings. Am J Cardiol 1979;44:623–31.
  • Pratt CM , Francis MJ , Luck JC , Wyndham CR , Miller RR , Quinones MA . Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation with special reference to preceding arrhythmic events. J Am Coll Cardiol 1983;2:789–97.
  • El-Sherif N , Myerburg RJ , Scherlag BJ , Befeler B , Aranda JM , Castellanos A , Lazzara R . Electrocardiographic antecedents of primary ventricular fibrillation. Value of the R-on-T phenomenon in myocardial infarction. Br Heart J 1976;38:415–22.
  • Kapa S , Venkatachalam KL , Asirvatham SJ . The autonomic nervous system in cardiac electrophysiology: an elegant interaction and emerging concepts. Cardiol Rev 2010;18:275–84.
  • Hasdemir C , Ulucan C , Yavuzgil O , Yuksel A , Kartal Y , Simsek E , et al. Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiologic characteristics, and the predictors. J Cardiovasc Electrophysiol 2011;22:663–8.
  • Yarlagadda RK , Iwai S , Stein KM , Markowitz SM , Shah BK , Cheung JW , et al. Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract. Circulation 2005;112:1092–7.
  • Zhong L , Lee YH , Huang XM , Asirvatham SJ , Shen WK , Friedman PA , et al. Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: a single-center retrospective study. Heart Rhythm 2014;11:187–93.
  • Yokokawa M , Good E , Crawford T , Chugh A , Pelosi F Jr , Latchamsetty R , et al. Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes. Heart Rhythm 2013;10:172–5.
  • Baman TS , Lange DC , Ilg KJ , Gupta SK , Liu TY , Alguire C , et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm 2010;7:865–9.
  • Hasdemir C , Yuksel A , Camli D , Kartal Y , Simsek E , Musayev O , et al. Late gadolinium enhancement CMR in patients with tachycardia-induced cardiomyopathy caused by idiopathic ventricular arrhythmias. Pacing Clin Electrophysiol 2012;35:465–70.
  • Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 1989;321:406–12.
  • Hallstrom AP , Cobb LA , Yu BH , Weaver WD , Fahrenbruch CE . An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol 1991;68:1025–31.
  • Pacifico A , Hohnloser SH , Williams JH , Tao B , Saksena S , Henry PD , Prystowsky EN . Prevention of implantable-defibrillator shocks by treatment with sotalol. N Eng J Med 1999;340:1855–62.
  • Connolly SJ , Dorian P , Roberts RS , Gent M , Bailin S , Fain ES , et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 2006;295:165–71.
  • Bokhari F , Newman D , Greene M , Korley V , Mangat I , Dorian P . Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004;110:112–16.
  • Pinter A , Akhtari S , O’Connell T , O’Donnell S , Mangat I , Korley V , et al. Efficacy and safety of dofetilide in the treatment of frequent ventricular tachyarrhythmias after amiodarone intolerance or failure. J Am Coll Cardiol 2011;57:380–1.
  • Baquero GA , Banchs JE , Depalma S , Young SK , Penny-Peterson ED , Samii SM , et al. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. J Cardiovasc Electrophysiol 2012;23:296–301.
  • Dorian P , Borggrefe M , Al-Khalidi HR , Hohnloser SH , Brum JM , Tatla DS , et al. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 2004;110:3646–54.
  • Singer I , Al-Khalidi H , Niazi I , Tchou P , Simmons T , Henthorn R , et al. Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators. J Am Coll Cardiol 2004;43:39–43.
  • Exner DV , Reiffel JA , Epstein AE , Ledingham R , Reiter MJ , Yao Q , et al. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol 1999;34:325–33.
  • Hreybe H , Bedi M , Ezzeddine R , Barrington W , Jain S , Ngwu O , Saba S . Indications for internal cardioverter defibrillator implantation predict time to first shock and the modulating effect of beta-blockers. Am Heart J 2005;150:1064.
  • Seidl K , Hauer B , Schwick NG , Zahn R , Senges J . Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator. Am J Cardiol 1998;82:744–8.
  • Finzi AA , Latini R , Barlera S , Rossi MG , Ruggeri A , Mezzani A , et al. Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca (GISSI-HF) trial. Am Heart J 2011;161:338–43.e1.
  • Madsen T , Christensen JH , Thogersen AM , Schmidt EB , Toft E . Intravenous infusion of n-3 polyunsaturated fatty acids and inducibility of ventricular tachycardia in patients with implantable cardioverter defibrillator. Europace 2010;12:941–6.
  • Metcalf RG , Sanders P , James MJ , Cleland LG , Young GD . Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol 2008;101:758–61.
  • Brouwer IA , Zock PL , Camm AJ , Böcker D , Hauer RN , Wever EF , et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 2006;295:2613–19.
  • Raitt MH , Connor WE , Morris C , Kron J , Halperin B , Chugh SS , et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005;293:2884–91.
  • Khoueiry G , Abi Rafeh N , Sullivan E , Saiful F , Jaffery Z , Kenigsberg DN , et al. Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias? A meta-analysis of randomized trials. Heart Lung 2013;42:251–6.
  • Verrier RL , Pagotto VP , Kanas AF , Sobrado MF , Nearing BD , Zeng D , Belardinelli L . Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia. Heart Rhythm 2013;10:121–7.
  • Bunch TJ , Mahapatra S , Murdock D , Molden J , Weiss JP , May HT , et al. Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. Pacing Clin Electrophysiol 2011;34:1600–6.
  • Vizzardi E , D’Aloia A , Salghetti F , Aljassim O , Raweh A , Bonadei I , et al. Efficacy of ranolazine in a patient with idiopathic dilated cardiomyopathy and electrical storm. Drug Discov Ther 2013;7:43–5.
  • Yeung E , Krantz MJ , Schuller JL , Dale RA , Haigney MC . Ranolazine for the suppression of ventricular arrhythmia: a case series. Ann Noninv Electrocardiol 2014;19:345–50.
  • Connolly SJ , Gent M , Roberts RS , Dorian P , Roy D , Sheldon RS , et al. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297–302.
  • Kuck KH , Cappato R , Siebels J , Ruppel R . Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748–54.
  • A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576–83.
  • Epstein AE , DiMarco JP , Ellenbogen KA , Estes NA 3rd , Freedman RA , Gettes LS , et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the american college of cardiology foundation/american heart association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol 2013;61:e6–75.
  • Kadish A , Dyer A , Daubert JP , Quigg R , Estes NA , Anderson KP , et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151–8.
  • Carson P , Anand I , O’Connor C , Jaski B , Steinberg J , Lwin A , et al. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. J Am Coll Cardiol 2005;46:2329–34.
  • Greenberg H , Case RB , Moss AJ , Brown MW , Carroll ER , Andrews ML . Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004;43:1459–65.
  • Packer DL , Prutkin JM , Hellkamp AS , Mitchell LB , Bernstein RC , Wood F , et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation 2009;120:2170–6.
  • Mitchell LB , Pineda EA , Titus JL , Bartosch PM , Benditt DG . Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation. J Am Coll Cardiol 2002;39:1323–8.
  • Duray GZ , Schmitt J , Richter S , Israel CW , Hohnloser SH . Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period. Europace 2009;11:1462–8.
  • Zagrodzky JD , Ramaswamy K , Page RL , Joglar JA , Sheehan CJ , Smith ML , Hamdan MH . Biventricular pacing decreases the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol 2001;87:1208–10.
  • Voigt A , Barrington W , Ngwu O , Jain S , Saba S . Biventricular pacing reduces ventricular arrhythmic burden and defibrillator therapies in patients with heart failure. Clin Cardiol 2006;29:74–7.
  • Manfredi JA , Al-Khatib SM , Shaw LK , Thomas L , Fogel RI , Padanilam B , et al. Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias. Circ Arrhythm Electrophysiol 2013;6:257–64.
  • Berger T , Hanser F , Hintringer F , Poelzl G , Fischer G , Modre R , et al. Effects of cardiac resynchronization therapy on ventricular repolarization in patients with congestive heart failure. J Cardiov Electrophysiol 2005;16:611–17.
  • Cabanelas N , Oliveira M , Nogueira da Silva M , Cunha P , Valente B , Lousinha A , et al. The proarrhythmic effect of cardiac resynchronization therapy: an issue that should be borne in mind. Rev Port Cardiol 2014;33:309.e1–7.
  • Kantharia BK , Patel JA , Nagra BS , Ledley GS . Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade. Europace 2006;8:625–8.
  • Mykytsey A , Maheshwari P , Dhar G , Razminia M , Zheutlin T , Wang T , Kehoe R , et al. Ventricular tachycardia induced by biventricular pacing in patient with severe ischemic cardiomyopathy. J Cardiovasc Electrophysiol 2005;16:655–8.
  • Nayak HM , Verdino RJ , Russo AM , Gerstenfeld EP , Hsia HH , Lin D , et al. Ventricular tachycardia storm after initiation of biventricular pacing: incidence, clinical characteristics, management, and outcome. J Cardiovasc Electrophysiol 2008;19:708–15.
  • Roque C , Trevisi N , Silberbauer J , Oloriz T , Mizuno H , Baratto F , et al. Electrical storm induced by cardiac resynchronization therapy is determined by pacing on epicardial scar and can be successfully managed by catheter ablation. Circ Arrhythm Electrophysiol 2014;7:1064–9.
  • Fish JM , Brugada J , Antzelevitch C . Potential proarrhythmic effects of biventricular pacing. J Am Coll Cardiol 2005;46:2340–7.
  • Godemann F , Butter C , Lampe F , Linden M , Schlegl M , Schultheiss HP , Behrens S . Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator. Clin Cardiol 2004;27:321–6.
  • Goodman M , Hess B . Could implantable cardioverter defibrillators provide a human model supporting the learned helplessness theory of depression? Gen Hosp Psychiatry 1999;21:382–5.
  • Whang W , Albert CM , Sears SF Jr , Lampert R , Conti JB , Wang PJ , et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 2005;45:1090–5.
  • Poole JE , Johnson GW , Hellkamp AS , Anderson J , Callans DJ , Raitt MH , et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009–17.
  • Bencardino G , Di Monaco A , Rio T , Frontera A , Santangeli P , Leo M , et al. The association between ICD interventions and mortality is independent of their modality: clinical implications. J Cardiovasc Electrophysiol 2014;25:1363–7.
  • Larsen GK , Evans J , Lambert WE , Chen Y , Raitt MH . Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2011;8:1881–6.
  • Sweeney MO , Sherfesee L , DeGroot PJ , Wathen MS , Wilkoff BL . Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010;7:353–60.
  • Moss AJ , Schuger C , Beck CA , Brown MW , Cannom DS , Daubert JP , et al. Reduction in Inappropriate Therapy and Mortality through ICD Programming. N Eng J Med 2012;367:2275–83.
  • Ruwald AC , Schuger C , Moss AJ , Kutyifa V , Olshansky B , Greenberg H , et al. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Circ Arrhythm Electrophysiol 2014;7:785–92.
  • Josephson M . Evaluation of electrical therapy for arrhythmias. Clinical cardiac electrophysiology. Philadelphia, PA: Lippinocott, Williams and Wilkins; 2008.
  • Wathen MS , Sweeney MO , DeGroot PJ , Stark AJ , Koehler JL , Chisner MB , et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001;104:796–801.
  • Wathen MS , DeGroot PJ , Sweeney MO , Stark AJ , Otterness MF , Adkisson WO et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004;110:2591–6.
  • Gasparini M , Proclemer A , Klersy C , Kloppe A , Lunati M , Ferrer JB , et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA 2013;309:1903–11.
  • Kloppe A , Proclemer A , Arenal A , Lunati M , Martìnez Ferrer JB , Hersi A , et al. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the avoid delivering therapies for nonsustained arrhythmias in ICD Patients III (ADVANCE III) trial. Circulation 2014;130:308–14.
  • Josephson ME , Harken AH , Horowitz LN . Endocardial excision: a new surgical technique for the treatment of recurrent ventricular tachycardia. Circulation 1979;60:1430–9.
  • Miller JM , Kienzle MG , Harken AH , Josephson ME . Subendocardial resection for ventricular tachycardia: predictors of surgical success. Circulation 1984;70:624–31.
  • Gepstein L , Hayam G , Ben-Haim SA . A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation 1997;95:1611–22.
  • Nademanee K , Kosar EM . A nonfluoroscopic catheter-based mapping technique to ablate focal ventricular tachycardia. Pacing Clin Electrophysiol 1998;21:1442–7.
  • Cassidy DM , Vassallo JA , Miller JM , Poll DS , Buxton AE , Marchlinski FE , Josephson ME . Endocardial catheter mapping during sinus rhythm: relation of underlying heart disease and ventricular arrhythmia. Circulation 1986;73:645–52.
  • Cassidy DM , Vassallo JA , Miller JM , Poll DS , Buxton AE , Marchlinski FE , Josephson ME . Endocardial catheter mapping in patients in sinus rhythm: relationship to underlying heart disease and ventricular arrhythmias. Circulation 1986;73:645–52.
  • Marchlinski FE , Callans DJ , Gottlieb CD , Zado E . Linear ablation lesions for control of unmappable ventricular tachycardia. Circulation 2000;101:1288–96.
  • Ellison KE , Friedman PL , Ganz LI , Stevenson WG . Entrainment mapping and radiofrequency catheter ablation of ventricular. J Am Coll Cardiol 1998;32:724–8.
  • Stevenson WG , Khan H , Sager P , Saxon LA , Middlekauff HR , Natterson PD , Wiener I . Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993;88:1647–70.
  • El-Shalakany A , Hadjis T , Papageorgiou P , Monahan K , Epstein L , Josephson ME . Entrainment/mapping criteria for the prediction of termination of ventricular tachycardia by single radiofrequency lesion in patients with coronary artery disease. Circulation 1999;99:2283–9.
  • Morady F , Harvey M , Kalbfleisch SJ , El-Atassi R , Calkins H , Langberg JJ . Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation 1993;87:363–72.
  • El Kadri M , Yokokawa M , Labounty T , Mueller G , Crawford T , Good E , et al. Effect of ablation of frequent premature ventricular complexes on left ventricular function in patients with nonischemic cardiomyopathy. Heart Rhythm 2015;12:706–13.
  • Sarrazin JF , Labounty T , Kuhne M , Crawford T , Armstrong WF , Desjardins B , et al. Impact of radiofrequency ablation of frequent post-infarction premature ventricular complexes on left ventricular ejection fraction. Heart Rhythm 2009;6:1543–9.
  • Kim YH , Sosa-Suarez G , Trouton TG , O’Nunain SS , Osswald S , McGovern BA , et al. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation 1994;89:1094–102.
  • Marchlinski FE , Callans DJ , Gottlieb CD , Zado E . Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000;101:1288–96.
  • Rothman SA , Hsia HH , Cossu SF , Chmielewski IL , Buxton AE , Miller JM . Radiofrequency catheter ablation of postinfarction ventricular tachycardia: long-term success and the significance of inducible nonclinical arrhythmias. Circulation 1997;96:3499–508.
  • Stevenson WG , Wilber DJ , Natale A , Jackman WM , Marchlinski FE , Talbert T , et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation 2008;118:2773–82.
  • Jais P , Maury P , Khairy P , Sacher F , Nault I , Komatsu Y , et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation 2012;125:2184–96.
  • Di Biase L , Santangeli P , Burkhardt DJ , Bai R , Mohanty P , Carbucicchio C , et al. Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol 2012;60:132–41.
  • Reddy VY , Reynolds MR , Neuzil P , Richardson AW , Taborsky M , Jongnarangsin K , et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657–65.
  • Kuck KH , Schaumann A , Eckardt L , Willems S , Ventura R , Delacrétaz E , et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010;375:31–40.
  • Delacretaz E , Brenner R , Schaumann A , Eckardt L , Willems S , Pitschner HF , et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): an on-treatment analysis. J Cardiovasc Electrophysiol 2013;24:525–9.
  • Dinov B , Fiedler L , Schönbauer R , Bollmann A , Rolf S , Piorkowski C , et al. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the prospective heart centre of leipzig VT (HELP-VT) Study. Circulation 2014;129:728–36.
  • Sosa E , Scanavacca M , d’Avila A , Pilleggi F . A new technique to perform epicardial mapping in the electrophysiology. J Cardiovasc Electrophysiol 1996;7:531–6.
  • Sosa E , Scanavacca M , D’Avila A , Piccioni J , Sanchez O , Velarde JL , et al. Endocardial and epicardial ablation guided by nonsurgical transthoracic. J Cardiovasc Electrophysiol 1998;9:229–39.
  • Sosa E , Scanavacca M , d’Avila A , Pilleggi F . A new technique to perform epicardial mapping in the electrophysiology. J Cardiovasc Electrophysiol 1996;7:531–6.
  • Tokuda M , Sobieszczyk P , Eisenhauer AC , Kojodjojo P , Inada K , Koplan BA , et al. Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update. Circ Arrhythm Electrophysiol 2011;4:889–96.
  • Sapp JL , Beeckler C , Pike R , Parkash R , Gray CJ , Zeppenfeld K , et al. Initial human feasibility of infusion needle catheter ablation for refractory ventricular tachycardia. Circulation 2013;128:2289–95.
  • Gizurarson S , Spears D , Sivagangabalan G , Farid T , Ha AC , Massé S , et al. Bipolar ablation for deep intra-myocardial circuits: human ex vivo development and in vivo experience. Europace 2014;16:1684–8.
  • Sinha AM , Schmidt M , Marschang H , Gutleben K , Ritscher G , Brachmann J , Marrouche NF . Role of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy. Pacing Clin Electrophysiol 2009;32:286–90.
  • Marrouche NF , Verma A , Wazni O , Schweikert R , Martin DO , Saliba W , et al. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol 2004;43:1715–20.
  • Schwartz PJ , Locati EH , Moss AJ , Crampton RS , Trazzi R , Ruberti U . Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report. Circulation 1991;84:503–11.
  • Hayase J , Patel J , Narayan SM , Krummen DE . Percutaneous stellate ganglion block suppressing VT and VF in a patient refractory to VT ablation. J Cardiovasc Electrophysiol 2013;24:926–8.
  • Vaseghi M , Gima J , Kanaan C , Ajijola OA , Marmureanu A , Mahajan A , Shivkumar K . Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart Rhythm 2014;11:360–6.
  • Krum H , Schlaich M , Whitbourn R , Sobotka PA , Sadowski J , Bartus K , et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009;373:1275–81.
  • Symplicity HTNI . Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011;57:911–17.
  • Huang B , Yu L , Scherlag BJ , Wang S , He B , Yang K , et al. Left Renal Nerves Stimulation Facilitates Ischemia-Induced Ventricular Arrhythmia by Increasing Nerve Activity of Left Stellate Ganglion. J Cardiov Electrophysiol 2014;25:1249–56.
  • Ukena C , Bauer A , Mahfoud F , Schreieck J , Neuberger HR , Eick C , et al. Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol 2012;101:63–7.
  • Hoffmann BA , Steven D , Willems S , Sydow K . Renal sympathetic denervation as an adjunct to catheter ablation for the treatment of ventricular electrical storm in the setting of acute myocardial infarction. J Cardiovasc Electrophysiol 2013;24:1175–8.
  • Remo BF , Preminger M , Bradfield J , Mittal S , Boyle N , Gupta A , et al. Safety and efficacy of renal denervation as a novel treatment of ventricular tachycardia storm in patients with cardiomyopathy. Heart Rhythm 2014;11:541–6.
  • Bhatt DL , Kandzari DE , O’Neill WW , D’Agostino R , Flack JM , Katzen BT , et al. A Controlled Trial of Renal Denervation for Resistant Hypertension. N Eng J Med 2014;370:1393–401.
  • Grimaldi R , de Luca A , Kornet L , Castagno D , Gaita F . Can spinal cord stimulation reduce ventricular arrhythmias? Heart Rhythm 2012;9:1884–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.